Imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: A therapeutic goal has been reached

Imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: A therapeutic goal has been reached

Bibliographic Details
Main Author: Massimo Breccia
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:EClinicalMedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537020300213
id doaj-e570449729534a618a016255815bc83d
record_format Article
spelling doaj-e570449729534a618a016255815bc83d2020-11-25T02:40:08ZengElsevierEClinicalMedicine2589-53702020-02-0119Imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: A therapeutic goal has been reachedMassimo Breccia0Correspondence: Massimo Breccia, MD, Hematology, Department of Translational and Precision Medicine, Sapienza University, Via Benevento 6, 00161 Rome, Italy.; Hematology, Department of Translational and Precision Medicine, Sapienza University, Azienda Policlinico Umberto 1, Rome, Italyhttp://www.sciencedirect.com/science/article/pii/S2589537020300213
collection DOAJ
language English
format Article
sources DOAJ
author Massimo Breccia
spellingShingle Massimo Breccia
Imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: A therapeutic goal has been reached
EClinicalMedicine
author_facet Massimo Breccia
author_sort Massimo Breccia
title Imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: A therapeutic goal has been reached
title_short Imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: A therapeutic goal has been reached
title_full Imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: A therapeutic goal has been reached
title_fullStr Imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: A therapeutic goal has been reached
title_full_unstemmed Imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: A therapeutic goal has been reached
title_sort imatinib improved the overall survival of chronic myeloid leukemia patients in low- and middle-income countries: a therapeutic goal has been reached
publisher Elsevier
series EClinicalMedicine
issn 2589-5370
publishDate 2020-02-01
url http://www.sciencedirect.com/science/article/pii/S2589537020300213
work_keys_str_mv AT massimobreccia imatinibimprovedtheoverallsurvivalofchronicmyeloidleukemiapatientsinlowandmiddleincomecountriesatherapeuticgoalhasbeenreached
_version_ 1724782924534906880

Similar Items